Phase 1 Study of HSVTK-CD34 Modified T Cells Therapy Following Haematopoietic Stem Cell Transplantation (HSCT) without Serotherapy (2012)
Attributed to:
BRIC: Packaging cell lines for inherently manufacturable viral vectors
funded by
BBSRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 20
Parent Publication: MOLECULAR THERAPY
ISSN: 1525-0016